Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Paragraf
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:CEO |
gptkb:Michael_Heltzen
|
| gptkbp:focus |
molecular diagnostics
CRISPR detection biocompatible electronics |
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
gptkb:Michael_Heltzen
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cardea Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Biosignal_Processing_Unit_(BPU)
|
| gptkbp:technology |
biosensors
graphene-based transistors |
| gptkbp:website |
https://www.cardeabio.com/
|
| gptkbp:bfsParent |
gptkb:Nessan_Bermingham
|
| gptkbp:bfsLayer |
7
|